Target intelligence / Profile preview

Undecaprenyl-phosphate N-acetylglucosaminyl 1-phosphate transferase (TagO)

Target
TagO
Molecular classification
Enzyme, Transferase, Glycosyltransferase
01

Overview

Undecaprenyl-phosphate N-acetylglucosaminyl 1-phosphate transferase (TagO) is an essential bacterial membrane enzyme that catalyzes the first committed step in the biosynthesis of wall teichoic acids (WTAs) in Gram-positive bacteria. Specifically, it transfers N-acetylglucosamine-1-phosphate (GlcNAc-1-P) from UDP-GlcNAc to the lipid carrier undecaprenyl phosphate (Und-P). WTAs are crucial components of the Gram-positive cell wall, playing key roles in cell division, cell shape maintenance, and virulence. Inhibition or deletion of TagO leads to a lack of WTAs, resulting in morphological defects, increased susceptibility to host immune factors like lysozyme, and impaired biofilm formation. Consequently, TagO is considered an attractive target for the development of novel antibacterial agents, particularly against drug-resistant pathogens like methicillin-resistant Staphylococcus aureus (MRSA). Natural products such as tunicamycin and CPZEN-45 have been shown to target TagO, although off-target inhibition of mammalian glycosylation enzymes presents a significant therapeutic challenge.

Other names
UDP-GlcNAc:undecaprenyl-phosphate GlcNAc-1-phosphate transferaseUDP-N-acetylglucosamine-undecaprenyl-phosphate N-acetylglucosaminephosphotransferaseGlcNAc-P-P-Und synthaseTarO
02

Mechanism of action

Inhibitor

03

Biological functions

Cell wall biogenesisTeichoic acid biosynthesisPeptidoglycan cross-linking regulation
04

Disease associations

Infection
05

Safety considerations

Off-target toxicityInhibition of mammalian UDP-GlcNAc:dolichyl-phosphate N-acetylglucosaminephosphotransferase (GPT)
06

Interacting drugs

1 more in the full profile.

Beyond the preview

Go deeper on Undecaprenyl-phosphate N-acetylglucosaminyl 1-phosphate transferase (TagO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Undecaprenyl-phosphate N-acetylglucosaminyl 1-phosphate transferase (TagO).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call